• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组聚(ADP - 核糖)聚合酶的纯化

Purification of recombinant poly(ADP-ribose) polymerases.

作者信息

Amé Jean-Christophe, Kalisch Thomas, Dantzer Françoise, Schreiber Valérie

机构信息

Groupe Poly(ADP-ribosyl)ation et Intégrité du Génome, FRE3211 du CNRS, École Supérieure de Biotechnologie de, Strasbourg, France.

出版信息

Methods Mol Biol. 2011;780:135-52. doi: 10.1007/978-1-61779-270-0_9.

DOI:10.1007/978-1-61779-270-0_9
PMID:21870259
Abstract

The purification of Poly(ADP-ribose) polymerases from overexpressing cells (Sf9 insect cells, Escherichia coli) has been updated to a fast and reproducible three chromatographic steps protocol. After cell lysis, proteins from the crude extract are separated on a Heparine Sepharose™ column. The PARP-containing fractions are then affinity purified on a 3-aminobenzamide Sepharose™ chromatographic step. The last contaminants and the 3-methoxybenzamide used to elute the PARP from the previous affinity column are removed on the high-performance strong cations exchanger Source™ 15S matrix. The columns connected to an ÄKTA™ purifier system allow the purification of PARPs in 3 days with a high-yield recovery. As described in the protocol, more than 11 mg of pure and highly active mouse PARP-2 can be obtained from 1 L of Sf9 insect cell culture.

摘要

从过表达细胞(Sf9昆虫细胞、大肠杆菌)中纯化聚(ADP - 核糖)聚合酶的方法已更新为一种快速且可重复的三步色谱法方案。细胞裂解后,粗提物中的蛋白质在肝素琼脂糖™柱上进行分离。然后,含PARP的组分在3 - 氨基苯甲酰胺琼脂糖™色谱步骤中进行亲和纯化。最后,使用高性能强阳离子交换剂Source™ 15S基质去除上一步亲和柱洗脱PARP时使用的3 - 甲氧基苯甲酰胺及残留污染物。连接到ÄKTA™纯化系统的柱子可在3天内实现PARP的高产量纯化回收。如该方案所述,从1 L Sf9昆虫细胞培养物中可获得超过11 mg的纯且高活性的小鼠PARP - 2。

相似文献

1
Purification of recombinant poly(ADP-ribose) polymerases.重组聚(ADP - 核糖)聚合酶的纯化
Methods Mol Biol. 2011;780:135-52. doi: 10.1007/978-1-61779-270-0_9.
2
Purification of Recombinant Human PARP-3.重组人聚(ADP-核糖)聚合酶-3的纯化
Methods Mol Biol. 2017;1608:373-394. doi: 10.1007/978-1-4939-6993-7_24.
3
Purification of Recombinant Human PARP-3.
Methods Mol Biol. 2023;2609:419-441. doi: 10.1007/978-1-0716-2891-1_26.
4
Production, extraction, and purification of human poly(ADP-ribose) polymerase-1 (PARP-1) with high specific activity.
Protein Expr Purif. 2001 Dec;23(3):453-8. doi: 10.1006/prep.2001.1513.
5
Cytoplasmic poly(ADP-ribose)polymerase from mouse plasmacytoma free messenger ribonucleoprotein particles: purification and characterization.
Biochem Biophys Res Commun. 1993 Sep 15;195(2):558-64. doi: 10.1006/bbrc.1993.2082.
6
Overproduction and large-scale purification of the human poly(ADP-ribose) polymerase using a baculovirus expression system.
Gene. 1992 May 15;114(2):279-83. doi: 10.1016/0378-1119(92)90588-g.
7
Purification of the poly-ADP-ribose polymerase-like thermozyme from the archaeon Sulfolobus solfataricus.从嗜热栖热放线菌中纯化聚腺苷二磷酸核糖聚合酶样热酶。
Methods Mol Biol. 2011;780:443-60. doi: 10.1007/978-1-61779-270-0_27.
8
Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo.体外和体内聚(ADP - 核糖)代谢的生化研究方法。
Anal Biochem. 1995 May 1;227(1):1-13. doi: 10.1006/abio.1995.1245.
9
Purification and properties of poly(ADP-ribose)polymerase from Crithidia fasciculata. Automodification and poly(ADP-ribosyl)ation of DNA topoisomerase I.来自克氏锥虫的聚(ADP-核糖)聚合酶的纯化及性质。DNA拓扑异构酶I的自身修饰和聚(ADP-核糖基)化作用。
Mol Biochem Parasitol. 2004 Jun;135(2):211-9. doi: 10.1016/j.molbiopara.2004.02.005.
10
A nondenaturing purification scheme for the DNA-binding domain of poly(ADP-ribose) polymerase, a structure-specific DNA-binding protein.一种针对聚(ADP - 核糖)聚合酶(一种结构特异性DNA结合蛋白)的DNA结合结构域的非变性纯化方案。
Protein Expr Purif. 1998 Oct;14(1):79-86. doi: 10.1006/prep.1998.0919.

引用本文的文献

1
Deciphering the dark side of histone ADP-ribosylation: what structural features of damaged nucleosome regulate the activities of PARP1 and PARP2.解读组蛋白ADP核糖基化的阴暗面:受损核小体的哪些结构特征调节PARP1和PARP2的活性。
Nucleic Acids Res. 2025 Sep 5;53(17). doi: 10.1093/nar/gkaf864.
2
Amphiphilic Oligonucleotide Derivatives as a Tool to Study DNA Repair Proteins.两亲性寡核苷酸衍生物作为研究DNA修复蛋白的工具
Int J Mol Sci. 2025 Jul 23;26(15):7078. doi: 10.3390/ijms26157078.
3
Poly(ADP-ribose)polymerase 2 is zinc-dependent enzyme and nucleosome reorganizer.
聚(ADP-核糖)聚合酶2是一种锌依赖性酶和核小体重组器。
Cell Mol Life Sci. 2025 Jun 30;82(1):267. doi: 10.1007/s00018-025-05785-8.
4
HPF1 Regulates Pol β Efficiency in Nucleosomes via the Modulation of Total Poly(ADP-Ribose) Synthesis.HPF1通过调节总聚(ADP-核糖)合成来调控核小体中Pol β的效率。
Int J Mol Sci. 2025 Feb 20;26(5):1794. doi: 10.3390/ijms26051794.
5
Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action.氨甲基吗啉代核苷作为PARP1和PARP2的新型抑制剂:其选择性及作用机制的实验与分子模拟分析
Int J Mol Sci. 2024 Nov 22;25(23):12526. doi: 10.3390/ijms252312526.
6
Divalent and multivalent cations control liquid-like assembly of poly(ADP-ribosyl)ated PARP1 into multimolecular associates in vitro.二价和多价阳离子控制聚(ADP-核糖基)化 PARP1 在体外形成多分子聚集体的液态样组装。
Commun Biol. 2024 Sep 15;7(1):1148. doi: 10.1038/s42003-024-06811-4.
7
A Knockout of Poly(ADP-Ribose) Polymerase 1 in a Human Cell Line: An Influence on Base Excision Repair Reactions in Cellular Extracts.一个人源细胞系中聚(ADP-核糖)聚合酶 1 的敲除:对细胞抽提物中碱基切除修复反应的影响。
Cells. 2024 Feb 6;13(4):302. doi: 10.3390/cells13040302.
8
Self-Penetrating Oligonucleotide Derivatives: Features of Self-Assembly and Interactions with Serum and Intracellular Proteins.自穿透寡核苷酸衍生物:自组装特征及其与血清和细胞内蛋白质的相互作用
Pharmaceutics. 2023 Dec 14;15(12):2779. doi: 10.3390/pharmaceutics15122779.
9
Cas9 is mostly orthogonal to human systems of DNA break sensing and repair.Cas9 与人类的 DNA 断裂感应和修复系统大多是正交的。
PLoS One. 2023 Nov 29;18(11):e0294683. doi: 10.1371/journal.pone.0294683. eCollection 2023.
10
PARP3 Affects Nucleosome Compaction Regulation.PARP3 影响核小体紧缩调控。
Int J Mol Sci. 2023 May 20;24(10):9042. doi: 10.3390/ijms24109042.